MobileNews

Realme 5 four-cam setup detailed

The CEO of Realme India changed his Twitter name yesterday, revealing the new name of the incoming four-camera smartphone – it will be Realme 5. Today the company announced on Weibo more details about the 64 MP main shooter.

Screenshots from the camera presentation
Screenshots from the camera presentation
Screenshots from the camera presentation
Screenshots from the camera presentation

Screenshots from the camera presentation

The Realme 5 will have the Samsung ISOCELL Bright GW1 sensor and it appears it will be the first phone to do so, even before the Redmi flagship. The size of it is 1/1.72”, with a pixel size of 0.8µm, making it even bigger than the 48 MP ISOCELL Bright GM1 platform, used in other phones from the same price range.

More screenshots from the camera presentation
More screenshots from the camera presentation
More screenshots from the camera presentation

More screenshots from the camera presentation

According to the images, the new camera will provide clearer images and better details when the photo is cropped/zoomed. The sensor is actually of the Tetracell variety so it’s intended to shoot in binned 16MP mode.

The secondary shooter will be super-wide-angle cam with 119-degree FoV and f/2.2 aperture, while the third one will have a dedicated macro lens that will allow you to take photos from up to 4 cm with impressive details.

Design-wise, it is obvious the camera will keep the design introduced in the Realme 3 Pro – two yellow circles around the main shooter, so people will know where to look when you’re taking their portrait shot.

Source 1 (in Chinese) • Source 2 | Via 1 • Via 2


Author: Yordan
Source: GSMArena

Realme Android


Related posts
CryptoNews

Hedge Funds Adopt Net Short Positions on BTC and ETH Futures, Kaiko Analysis Reveals

CryptoNews

Deadline Looms for Biden to Veto Congressional Overturn of SEC's Crypto Rules

CryptoNews

Justin Sun Advocates Supporting a Crypto-Friendly U.S. Presidential Candidate

AI & RoboticsNews

McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI

Sign up for our Newsletter and
stay informed!